Probiotics and prebiotics in pediatric diarrheal disorders

Expert Opinion on Pharmacotherapy

Volumn 14, Issue 4, 2013, Pages 397-409

  Vandenplas, Y ^a   De Greef, Elisabeth ^a   Hauser, Bruno ^a   Devreker, Thierry ^a   Veereman Wauters, G ^a  

^a UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

Author keywords

(antibiotic associated) diarrhea; Gastroenteritis; Inflammatory bowel disease; Irritable bowel syndrome; Prebiotic; Probiotic

Indexed keywords

PLACEBO; PREBIOTIC AGENT; PROBIOTIC AGENT;

ACUTE DIARRHEA; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC ASSOCIATED DIARRHEA; ANTIBIOTIC THERAPY; ARTIFICIAL MILK; BACTERIAL STRAIN; BLOODY DIARRHEA; CALCIUM ABSORPTION; CENTRAL VENOUS CATHETER; CHILDHOOD DISEASE; CHRONIC DIARRHEA; CLOSTRIDIUM DIFFICILE INFECTION; COGNITION; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; CROHN DISEASE; DIARRHEA; DIET SUPPLEMENTATION; DISEASE DURATION; DOSE RESPONSE; DRUG EFFICACY; DRUG MEGADOSE; FUNGAL STRAIN; GASTROENTERITIS; GOLD STANDARD; HUMAN; INFANT FEEDING; INFECTIOUS DIARRHEA; INTESTINE FLORA; INTRAVENOUS CATHETER; IRRITABLE COLON; LAW; MALNUTRITION; MEMORY; MORBIDITY; NECROTIZING ENTEROCOLITIS; NONHUMAN; PRESCRIPTION; PRIMARY PREVENTION; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECURRENT INFECTION; REFERENCE DATABASE; REHYDRATION; REVIEW; SACCHAROMYCES BOULARDII; SECONDARY PREVENTION; STATISTICAL SIGNIFICANCE; SYSTEMATIC REVIEW (TOPIC); TRAVELLER DIARRHEA; ULCERATIVE COLITIS; UPPER RESPIRATORY TRACT INFECTION;

CHILD; DIARRHEA; GASTROENTERITIS; HUMANS; INFLAMMATORY BOWEL DISEASES; IRRITABLE BOWEL SYNDROME; PREBIOTICS; PROBIOTICS; TREATMENT OUTCOME;

EID: 84874476049     PISSN: 14656566     EISSN: 17447666     Source Type: Journal    
DOI: 10.1517/14656566.2013.771632     Document Type: Review

References (107)

1. Johnson CL, Versalovic J. The human microbiome and its potential importance to pediatrics. Pediatrics 2012;129:950-60
2. Lilly DM, Stillwell RH. Probiotic growth promoting factors produced by microorganisms. Science 1965;147:747-8
3. Magrone T, Jirillo E. The interplay between the gut immune system and microbiota in health and disease: nutraceutical intervention for restoring intestinal homeostasis. Curr Pharm Des 2012;In press
4. Tissier H. Traitement des infections intestinales par la methode de la transformation de la flore bacterienne de l'intestin. C R Soc Biol 1906;60:359-61
5. Reid G. Microbiology: categorize probiotics to speed research. Nature 2012;485:446
6. Vanhee LME, Goeme F, Nelis HJ, Coenye T. Quality control of fifteen probiotic products containing Saccharomyces boulardii. J Appl Microbiol 2010;109:1745-52
7. Tung JM, Dolovich LR, Lee CH. Prevention of Clostridium difficile infection with Saccharomyces boulardii: a systematic review. Can J Gastroenterol 2009;23:817-21
8. Hicks PD, Hawthorne KM, Berseth CL, et al. Total calcium absorption is similar from infant formulas with and without prebiotics and exceeds that in human milk-fed infants. BMC Pediatr 2012;12:118
9. Temmerman R, Pot B, Huys G, Swings J. Identification and antibiotic susceptibility of bacterial isolates from probiotic products. Int J Food Microbiol 2003;81:1-10
10. Elliott E, Teversham K. An evaluation of nine probiotics available in South Africa, August 2003. SAMJ 2004;94:121-4
11. Ibnou-Zekri N, Blum S, Schiffrin EJ, von der Weid T. Divergent patterns of colonization and immune response elicited from two intestinal Lactobacillus strains that display similar properties in vitro. Infect Immun 2003;71:428-36
12. Marteau P, Pochart P, Bouhnik Y, et al. Survival of Lactobacillus acidophilus and Bifidobacterium sp. in the small intestine following ingestion in fermented milk. A rational basis for the use of probiotics in man. Gastroenterol Clin Biol 1992;16:25-8
13. Juntunen M, Kirjavainen PV, Ouwehand AC, et al. Adherence of probiotic bacteria to human intestinal mucus in healthy infants and during ROTAvirus infection. Clin Diagn Lab Immunol 2001;8:293-6
14. Ritchie ML, Romanuk TN. A meta-analysis of probiotic efficacy for gastrointestinal diseases. Plos One 2012;7:e34938
15. Vandenplas Y. Identification of probiotics by specific strain name. Aliment Pharmacol Ther 2012;35:860
16. Saavedra JM, Bauman NA, Oung I, et al. Feeding of Bifidobacterium bifidum and Streptococcus thermophilus to infants in hospital for prevention of diarrhoea and shedding of rotavirus. Lancet 1994;344:1046-9
17. Saran S, Gopalan S, Krishna TP. Use of fermented foods to combat stunting and failure to thrive. Nutrition 2002;18:393-6
18. Sazawal S, Dhingra U, Sarkar A, et al. Efficacy of milk fortified with a probiotic Bifidobacterium lactis (DR-10TM) and prebiotic galacto- oligosaccharides in prevention of morbidity and on nutritional status. Asia Pac J Clin Nutr 2004;13(Suppl):S28
19. Szajewska H, Kotowska M, Mrukowicz JZ, et al. Efficacy of Lactobacillus GG in prevention of nosocomial diarrhea in infants. J Pediatr 2001;138:361-5
20. Szajewska H, Setty M, Mrukowicz J, Guandalini S. Probiotics in gastrointestinal disease in children: hard and not-so-hard evidence of efficacy. J Pediatr Gastroenterol Nutr 2006;42:454-75
21. Agustina R, Kok FJ, van de Rest O, et al. Randomized trial of probiotics and calcium on diarrhea and respiratory tract infections in Indonesian children. Pediatrics 2012;129:e1155-64
22. Guandalini S. Probiotics for prevention and treatment of diarrhea. J Clin Gastroenterol 2011;45(Suppl):S149-53
23. Szajewska H, Wanke M, Patro B. Meta-analysis: the effects of Lactobacillus rhamnosus GG supplementation for the prevention of healthcare-associated diarrhoea in children. Aliment Pharmacol Ther 2011;34:1079-87
24. Bernaola Aponte G, Bada Mancilla CA, Carreazo Pariasca NY, Rojas Galarza RA. Probiotics for treating persistent diarrhoea in children. Cochrane Database Syst Rev 2010(11):CD007401
25. Sazawal S, Dhingra U, Hiremath G, et al. Prebiotic and probiotic fortified milk in prevention of morbidities among children: community-based, randomized, double-blind, controlled trial. PLoS One 2010;5:e12164
26. Mastretta E Longo P, Laccisaglia A, Balbo L, et al. Effect of a Lactobacillus GG and breast-feeding in the prevention of rotavirus nosocomial infection. J Pediatr Gastroenterol Nutr 2002;35:527-31
27. Chouraqui JP, Van Egroo LD, Fichot MC. Acidified milk formula supplemented with Bifidobacterium lactis: impact on infant diarrhea in residual care settings. J Pediatr Gastroenterol Nutr 2004;38:288-92
28. Thibault H, Aubert-Jacquin C, Goulet O. Effects of long-term consumption of a fermented infant formula (with Bifidoacterium Breve c50 and Streptococcus thermophilus 065) on acute diarrhea in healthy infants. J Pediatr Gastroenterol Nutr 2004;39:147-52
29. Agostoni C, Axelsson I, Braegger C, et al. ESPGHAN Committee on Nutrition. Probiotic bacteria in dietetic products for infants: a commentary by the ESPGHAN Committee on Nutrition. J Pediatr Gastroenterol Nutr 2004;38:365-74
30. Szajewska H, Mrukowicz JZ. Use of probiotics in children with acute diarrhea. Paediatr Drugs 2005;7:111-22
31. Braegger C, Chmielewska A, Decsi T, et al. ESPGHAN Committee on Nutriti on. Supplementation of infant formula with probiotics and/or prebiotics: a systematic review and comment by the ESPGHAN committee on nutrition. J Pediatr Gastroenterol Nutr 2011;52:238-50
32. Thomas DW, Greer FR. Clinical report: probiotics and prebiotics in pediatrics. Pediatrics 2010;126:1217-31
33. Salvini FJ. A specific prebiotic mixture added to starting infant formula has long-lasting bifidogenic effects. J Nutr 2011;141:1335-9
34. Ben XM. Low level of GOS in infant formula stimulates growth of intestinal Bifidobacteria and Lactobacilli. World J Gastroenterol 2008;14:6564-8
35. Arslanoglu S, Moro GE, Boehm G. Early supplementation of prebiotic oligosaccharides protects formula-fed infants against infections during the first 6 months of life. J Nutr 2007;137:2420-4
36. Isolauri E, Juntunen M, Rautanen T, et al. A human Lactobacillus strain (Lactobacillus casei sp strain GG) promotes recovery from acute diarrhea in children. Pediatrics 1991;88:90-7
37. Raza S, Graham SM, Allen SJ. Lactobacillus GG promotes recovery from acute nonbloody diarrhea in Pakistan. Pediatr Infect Dis J 1995;14:107-11
38. Shornikova AV, Isolauri E, Burkanova L, et al. A trial in the Karelian Republic of oral rehydration and Lactobacillus GG for treatment of acute diarrhoea. Acta Paediatr 1997;86:460-5
39. Shornikova AV, Casas IA, Mykkanen H, et al. T. Bacteriotherapy with Lactobacillus reuteri in Rotavirus gastroenteritis. Pediatr Infect Dis J 1997;16:1103-7
40. Guarino A, Berni Canani R, Spagnuolo MI, et al. Oral bacterial therapy reduces the duration of symptoms and viral excretion in children with mild diarrhea. J Pediatr Gastroenterol Nutr 1997;25:516-19
41. Guandalini S, Pensabene L, Zikri MA, et al. Lactobacillus GG administered in oral rehydration solution in children with acute diarrhea: a multicenter European trial. J Pediatr Gastroenterol Nutr 2000;30:214-16
42. Simakachorn N, Pichaipat V, Rithipornpaisarn P, et al. Clinical evaluation of the addition of lyophilized, heat-killed Lactobacillus acidophilus LB to oral rehydration therapy in the treatment of acute diarrhea in children. J Pediatr Gastroenterol Nutr 2000;30:68-72
43. Szymanski H, Pejcz J, Jawien M, et al. Treatment of acute infectious diarrhoea in infants and children with a mixture of three Lactobacillus rhamnosus strains - a randomized, double-blind, placebo-controlled trial. Aliment Pharmacol Ther 2006;23:247-53
44. Costa-Ribeiro H, Ribeiro TC, Mattos AP, et al. Limitations of probiotic therapy in acute, severe dehydrating diarrhea. J Pediatr Gastroenterol Nutr 2003;36:112-15
45. Khanna V, Alam S, Malik A. Efficacy of tyndalized Lactobacillus acidophilus in acute diarrhea. Indian J Pediatr 2005;72:935-8
46. Salazar-Lindo E, Miranda-Langschwager P, Campos-Sanchez M, et al. Lactobacillus casei strain GG in the treatment of infants with acute watery diarrhea: a randomized, double-blind, placebo controlled clinical trial [ISRCTN67363048]. BMC Pediatr 2004;4:18
47. Kowalska-Duplaga K, Fyderek K, Szajewska H, et al. Efficacy of Trilac in the treatment of acute diarrhoea in infants and young children - a multicentre, randomized, double-blind placebo-controlled study. Pediatria Wspołczesna 2004;3:295-9
48. Sarker SA, Sultana S, Fuchs GJ, et al. Lactobacillus paracasei strain ST11 has no effect on rotavirus but ameliorates the outcome of nonrotavirus diarrhea in children from Bangladesh. Pediatrics 2005;116:e221-8
49. Huang JS, Bousvaros A, Lee JW, et al. Efficacy of probiotic use in acute diarrhea in children: a meta-analysis. Dig Dis Sci 2002;47:2625-34
50. Szajewska H, Mrukowicz JZ. Probiotics in the treatment and prevention of acute infectious diarrhea in infants and children: a systematic review of published randomized, double-blind, placebo-controlled trials. J Pediatr Gastroenterol Nutr 2001;33:S17-25
51. Van Niel CW, Feudtner C, Garrison MM, Christakis DA. Lactobacillus therapy for acute infectious diarrhea in children: a meta-analysis. Pediatrics 2002;109:678-84
52. Hochter W, Chase D, Hagenhoff G. Saccharomyces boulardii bei akuter Erwachsenendiarrhoe. Munch Med Wschr 1990;132:188-92
53. Kurugol Z, Koturoglu G. Effects of Saccharomyces boulardii in children with acute diarrhoea. Acta Paediatr 2005;94:44-7
54. Villarruel G, Rubio DM, Lopez F, et al. Saccharomyces boulardii in acute childhood diarrhea: a randomized, placebo-controlled study. Acta Paediatr 2007;96:538-41
55. Castaneda C, Garcia E, Santa Cruz M, et al. Effects of Saccharomyces boulardii in children with chronic diarrhea, especially cases due to giardiasis. Revista Mexicana de Puericulturay Pediatria 1995;2:12-16
56. Mansour-Ghanaei F, Dehbashi N, Yazdanparast K, Shafaghi A. Efficacy of Saccharomyces boulardii with antibiotics in acute amoebiasis. World J Gastroenterol 2003;9:1832-3
57. Saint-Marc T, Rossello-Prats L, Touraine JL. Efficacy of Saccharomyces boulardii in the treatment of diarrhea in AIDS. Ann Med Interne (Paris) 1991;142:64-5
58. Billoo AG, Memon MA, Khaskheli SA, et al. A. Role of a probiotics (Saccharomyces boulardii) in the management and prevention of diarrhea. World J Gastroenterol 2006;12:4557-60
59. Allen SJ, Okoko B, Martinez E, et al. Probiotics for treating infectious diarrhea. Cochrane Database Syst Rev 2004(2):CD003048
60. Szajewska H, Ruszczynski M, Radzikowski A. Probiotics in the prevention of antibiotic-associated diarrhea in children: a meta-analysis of randomized controlled trials. J Pediatr 2006;149:367-72
61. Sazawal S, Hiremath G, Dhingra U, et al. Efficacy of probiotics in prevention of acute diarrhoea: a meta-analysis of masked, randomised, placebo-controlled trials. Lancet Infect Dis 2006;6:374-82
62. Francavilla R, Lionetti E, Castellaneta S, et al. Randomised clinical trial: lactobacillus reuteri DSM 17938 vs. placebo in children with acute diarrhoea-a double-blind study. Aliment Pharmacol Ther 2012;36:363-9
63. Alam S, Bhatnagar S. Current status of anti-diarrheal and anti-secretory drugs in the management of acute childhood diarrhea. Indian J Pediatr 2006;73:693-6
64. Vandenplas Y, De Hert S. Cost/benefit of synbiotics in acute infectious gastroenteritis: spend to save. Benef Microbes 2012;3:189-94
65. Erdogan O, Tanyeri B, Torun E, et al. The comparison of the efficacy of two different probiotics in Rotavirus gastroenteritis in children. J Trop Med 2012;2012:787240
66. Hoekstra JH, Szajewska H, Zikri MA, et al. Oral rehydration solution containing a mixture of non-digestible carbohydrates in the treatment of acute diarrhea: a multicenter randomized placebo controlled study on behalf of the ESPGHAN working group on intestinal infections. J Pediatr Gastroenterol Nutr 2004;39:239-45
67. Passariello A, Terrin G, Cecere G, et al. Randomised clinical trial: efficacy of a new synbiotic formulation containing Lactobacillus paracasei B21060 plus arabinogalactan and xilooligosaccharides in children with acute diarrhoea. Aliment Pharmacol Ther 2012;35:782-8
68. Vandenplas Y, De Hert SG; PROBIOTICAL-study group. Randomised clinical trial: the synbiotic food supplement Probiotical vs. placebo for acute gastroenteritis in children. Aliment Pharmacol Ther 2011;34:862-7
69. Shamir R, Makhoul IR, Etzioni A, Shehadeh N. Evaluation of a diet containing probiotics and zinc for the treatment of mild diarrheal illness in children younger than one year of age. J Am Coll Nutr 2005;24:370-5
70. Turck D, Bernet JP, Marx J, et al. Incidence and risk factors of oral antibiotic associated diarrhea in an outpatient pediatric population. J Pediatr Gastroenterol Nutr 2003;37:22-6
71. McFarland LV. Meta-analysis of probiotics for prevention of antibiotic associated diarrhea and the treatment of Clostridium difficile disease. Am J Gastroenterol 2006;101:812-22
72. Johnston BC, Goldenberg JZ, Vandvik PO, et al. Probiotics for the prevention of pediatric antibiotic-associated diarrhea. Cochrane Database Syst Rev 2011;11:CD004827
73. D'Souza AL, Rajkumar C, Cooke J, Bulpitt CJ. Probiotics in prevention of antibiotic associated diarrhoea: meta-analysis. BMJ 2002;324:1361
74. Kale-Pradhan PB, Jassal HK, Wilhelm SM. Role of Lactobacillus in the prevention of antibiotic-associated diarrhea: a meta-analysis. Pharmacotherapy 2010;30:119-26
75. Videlock EJ, Cremonini F. Meta-analysis: probiotics in antibiotic-associated diarrhoea. Aliment Pharmacol Ther 2012;35:1355-69
76. ESPGHAN Working Group on Probiotics and Prebiotics. Szajewska H, Weizman Z, Abu-Zekry M, et al. Inulin and Fructo-oligosaccharides for the prevention of antibiotic-associated diarrhea in children: report by the ESPGHAN Working Group on Probiotics and Prebiotics. J Pediatr Gastroenterol Nutr 2012;54:828-9
77. Katelaris PH, Salam I, Farthing MJ. Lactobacilli to prevent traveler's diarrhea? N Eng J Med 1995;333:1360-1
78. Hilton E, Kolakowski P, Singer C, Smith M. Efficacy of Lactobacillus GG as a diarrheal preventive in travelers. J Travel Med 1997;4:41-3
79. Oksanen PJ, Salminen S, Saxelin M, et al. Prevention of travellers' diarrhoea by Lactobacillus GG. Ann Med 1990;22:53-6
80. Kollaritsch H. Traveller's diarrhea among Austrian tourists to warm climate countries: II. Clinical features. Eur J Epidemiol 1989;5:355-62
81. McFarland LV. Probiotics and diarrhea. Ann Nutr Metab 2010;57(Suppl):10-11
82. Sartor RB. Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics, and prebiotics. Gastroenterology 2004;126:1620-33
83. Bousvaros A. A randomized, double-blind trial of Lactobacillus GG versus placebo in addition to standard maintenance therapy for children with Crohn's disease. Inflamm Bowel Dis 2005;11:833-9
84. Oliva S, Di Nardo G, Ferrari F, et al. Randomised clinical trial: the effectiveness of Lactobacillus reuteri ATCC 55730 rectal enema in children with active distal ulcerative colitis. Aliment Pharmacol Ther 2012;35:327-34
85. Miele E, Pascarella F, Giannetti E, et al. Effect of a probiotic preparation (VSL#3) on induction and maintenance of remission in children with ulcerative colitis. Am J Gastroenterol 2009;104:437-43
86. Park KT, Perez F, Tsai R, et al. Cost-effectiveness analysis of adjunct VSL#3 therapy versus standard medical therapy in pediatric ulcerative colitis. J Pediatr Gastroenterol Nutr 2011;53:489-96
87. Day AS. Use of complementary and alternative medicines by children and adolescents with inflammatory bowel disease. Paediatr Child Health 2004;40:681-4
88. Huertas-Ceballos AA, Logan S, Bennett C, Macarthur C. Dietary interventions for recurrent abdominal pain (RAP) and irritable bowel syndrome (IBS) in childhood. Cochrane Database Syst Rev 2009(1):CD003019
89. O'Mahony L, McCarthy J, Kelly P, et al. Lactobacillus and bifidobacterium in irritable bowel syndrome: symptom responses and relationship to cytokine profiles. Gastroenterology 2005;128:541-51
90. Bausserman M, Michail S. The use of Lactobacillus GG in irritable bowel syndrome in children: a double-blind randomized control trial. J Pediatr 2005;147:197-201
91. Guandalini S, Magazzu G, Chiaro A, et al. VSL#3 improves symptoms in children with irritable bowel syndrome: a multicenter, randomized, placebo-controlled, double-blind, crossover study. J Pediatr Gastroenterol Nutr 2010;51:24-30
92. Francavilla R, Miniello V, Magista AM, et al. A randomized controlled trial of Lactobacillus GG in children with functional abdominal pain. Pediatrics 2010;126:e1445-52
93. Horvath A, Dziechciarz P, Szajewska H. Meta-analysis: Lactobacillus rhamnosus GG for abdominal pain-related functional gastrointestinal disorders in childhood. Aliment Pharmacol Ther 2011;33:1302-10
94. Drago L, Mattina R, De Vecchi E, Toscano M. Phenotypic and genotypic antibiotic resistance in some probiotics proposed for medical use. Int J Antimicrob Agents 2013;In press
95. Rosander A, Connolly E, Roos S. Removal of antibiotic resistance gene-carrying plasmids from Lactobacillus reuteri ATCC 55730 and characterization of the resulting daughter strain, L. reuteri DSM 17938. Appl Environ Microbiol 2008;74:6032-40
96. Vieira de Souza F, Roque R, Silva Moreira JL, et al. Transfer of antibiotic resistance determinants between lactobacilli isolates from the gastrointestinal tract of chicken. Benef Microbes 2012;3:137-44
97. Fedorak RN, Madsen KI. Probiotics and prebiotics in gastrointestinal disorders. Curr Opin Gastroenterol 2004;20:146-55
98. Borriello SP, Hammes WP, Holzapfel W, et al. Safety of probiotics that contain Lactobacilli or Bifidobacteria. Clin Infect Dis 2003;36:775-80
99. Mackay AD, Taylor MB, Kibbler CC, Hamilton-Miller JM. Lactobacillus endocarditis caused by a probiotics organism. Clin Microbiol Infect 1999;5:290-2
100. Rautio M, Jousimies-Somer H, Kauma H, et al. Liver abscess due to a Lactobacillus rhamnosus strain indistinguishable from a L. rhamnosus strain GG. Clin Infect Dis 1999;28:1159-60
101. Cabana MD, Shane AL, Chao C, Oliva-Henker M. Probiotics in primary care pediatrics. Clin Pediatr 2006;45:405-10
102. Enache-Angoulvant A. Invasive Saccharomyces infection: a comprehensive review. Clin Infect Dis 2005;41:1559-68
103. Cassone M, Serra P, Mondello F, et al. Outbreak of Saccharomyces cerevisiae subtype boulardii fungemia in patients neighboring those treated with a probiotic preparation of the organism. Clin Microbiol 2003;41:5340-3
104. Jijon H, Backer J, Diaz H, et al. DNA from probiotic bacteria modulates murine and human epithelial and immune function. Gastroenterology 2004;126:1358-73
105. NASPGHAN Nutrition Report Committee. Michail S, Sylvester F, Fuchs G, Issenman R. Clinical efficacy of probiotics: review of the evidence with focus on children. J Pediatr Gastroenterol Nutr 2006;43:550-7
106. Dinleyici EC, Eren M, Ozen M, et al. Effectiveness and safety of Saccharomyces boulardii for acute infectious diarrhea. Expert Opin Biol Ther 2012;12:395-410
107. Kelesidis T, Pothoulakis C. Efficacy and safety of the probiotic Saccharomyces boulardii for the prevention and therapy of gastrointestinal disorders. Therap Adv Gastroenterol 2012;5:111-25